Table 3.
The indications for local cyclosporine use [37]
| Clinical situations | Indications |
|---|---|
| Selected ocular pathologies | Meibomian gland dysfunction |
| Dry eye disease, esp. severe Sjögren's syndrome dry eye | |
| Vernal keratoconjunctivitis (to improve pain and local inflammation) | |
| Thygeson's superficial punctate keratopathy | |
| Atopic keratoconjunctivitis | |
| Epidemic adenoviral keratoconjunctivitis (to reduce the number of subepithelial deposits and recurrence rate) | |
| Corneal ulcer (to reduce inflammation and improve healing) | |
| Mooren's ulcer | |
| Herpes simplex keratitis | |
| Neurotrophic keratopathy | |
| Anterior uveitis, esp. not responding to corticosteroids | |
| Sympathetic ophthalmia | |
| Autoimmune uveitis NOS | |
| Postoperative conditions | After cataract surgery (to minimise local inflammation in patients with primary and secondary dry eye syndrome) |
| After pterygium surgery (to reduce the recurrence) | |
| After glaucoma surgery | |
| After corneal transplant (to prevent graft rejection, in high-risk grafts) | |
| After refractive surgery (to improve corneal sensation – nerve fibre repair) |